Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

What's new

EMA approval of IntraBio’s Aqneursa marks a major milestone for the Department of Pharmacology, with further Phase 3 success in Ataxia Telangiectasia

On 21 January, the European Medicines Agency (EMA) approved Aqneursa, a new treatment for Niemann-Pick Disease Type C (NPC) in adults and children, marking a major milestone for research originating in the Department of Pharmacology. Aqneursa already received US FDA approval (September 2024), enabling patient access on both sides of the Atlantic.

Akerman group paper wins inaugural Sejnowski-Hinton Prize

Congratulations to Professor Colin Akerman and members of his team who have been awarded the inaugural Sejnowski-Hinton Prize for their groundbreaking 2016 paper “Random synaptic feedback weights support error backpropagation for deep learning”

New paper from the Viney group explores mechanisms of spatial disorientation

A new paper, entitled “Pathological tau alters head direction signaling and induces spatial disorientation”, has recently been published by the Viney group.

Behind the photographs: Shared pre-war histories of the British and German Pharmacological Societies

On Friday 3rd October the Department of Pharmacology hosted a unique event supported by the British and German Pharmacological Societies to explore their shared histories pre-war and the subsequent disruption of academic careers.

Upcoming talks and events